The endocannabinoid system: An emotional buffer in the modulation of memory function

Neurobiology of Learning and Memory

Volumn 112, Issue , 2014, Pages 30-43

  Morena, Maria ^a   Campolongo, Patrizia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anandamide; Cannabinoids; Emotional arousal; Memory modulation; Stress

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 7 PHENYL 1 [5 (2 PYRIDINYL) 2 OXAZOLYL] 1 HEPTANONE; ANANDAMIDE; CANNABINOID RECEPTOR AGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DEXANABINOL; ENDOCANNABINOID; JZL 184; JZL 195; METYRAPONE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; RIMONABANT; TETRAHYDROCANNABINOLIC ACID; UNCLASSIFIED DRUG; CANNABINOID;

AROUSAL; AVOIDANCE BEHAVIOR; EMOTIONAL STRESS; EMOTIONALITY; FEAR; HUMAN; MEMORY; MEMORY ACQUISITION; MEMORY CONSOLIDATION; MEMORY DISORDER; MEMORY EXTINCTION; MORRIS WATER MAZE TEST; NEUROMODULATION; NONHUMAN; REVIEW; TASK PERFORMANCE; ANIMAL; DRUG EFFECTS; EMOTION; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; AROUSAL; CANNABINOIDS; EMOTIONS; ENDOCANNABINOIDS; HUMANS; MEMORY; STRESS, PSYCHOLOGICAL;

EID: 84901942083     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2013.12.010     Document Type: Review

References (209)

1. Abush H., Akirav I. Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 2010, 20(10):1126-1138.
2. Aggleton J.P. The contribution of the amygdala to normal and abnormal emotional states. Trends in Neurosciences 1993, 16(8):328-333.
3. Akirav I. The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Frontiers in Behavioral Neuroscience 2011, 5:34.
4. Armario A. Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: Different pathways, common outcome. Trends in Pharmacological Sciences 2010, 31(7):318-325.
5. Atsak P., Hauer D., Campolongo P., Schelling G., McGaugh J.L., Roozendaal B. Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(9):3504-3509.
6. Atsak P., Roozendaal B., Campolongo P. Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience 2012, 204:104-116.
7. Azad S.C., Kurz J., Marsicano G., Lutz B., Zieglgansberger W., Rammes G. Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala. Learning & Memory 2008, 15(3):143-152.
8. Ballard M.E., Bedi G., de Wit H. Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images. Journal of Psychopharmacology 2012, 26(10):1289-1298.
9. Barad M., Gean P.W., Lutz B. The role of the amygdala in the extinction of conditioned fear. Biological Psychiatry 2006, 60(4):322-328.
10. Barna I., Zelena D., Arszovszki A.C., Ledent C. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: In vivo and in vitro studies in CB1 receptor knockout mice. Life Sciences 2004, 75(24):2959-2970.
11. Baxter M.G., Murray E.A. The amygdala and reward. Nature Reviews Neuroscience 2002, 3(7):563-573.
12. Berridge C.W., Schmeichel B.E., Espana R.A. Noradrenergic modulation of wakefulness/arousal. Sleep Medicine Reviews 2012, 16(2):187-197.
13. Bitencourt R.M., Pamplona F.A., Takahashi R.N. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. European Neuropsychopharmacology 2008, 18(12):849-859.
14. Bortolato M., Campolongo P., Mangieri R.A., Scattoni M.L., Frau R., Trezza V., et al. Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 2006, 31(12):2652-2659.
15. Bucherelli C., Baldi E., Mariottini C., Passani M.B., Blandina P. Aversive memory reactivation engages in the amygdala only some neurotransmitters involved in consolidation. Learning & Memory 2006, 13(4):426-430.
16. Busquets-Garcia A., Puighermanal E., Pastor A., de la Torre R., Maldonado R., Ozaita A. Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biological Psychiatry 2011, 70(5):479-486.
17. Campolongo P., Morena M., Scaccianoce S., Trezza V., Chiarotti F., Schelling G., et al. Novelty-induced emotional arousal modulates cannabinoid effects on recognition memory and adrenocortical activity. Neuropsychopharmacology 2013, 38:1276-1286.
18. Campolongo P., Ratano P., Manduca A., Scattoni M.L., Palmery M., Trezza V., et al. The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. Frontiers in Behavioral Neuroscience 2012, 6:11.
19. Campolongo P., Roozendaal B., Trezza V., Cuomo V., Astarita G., Fu J., et al. Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(19):8027-8031.
20. Campolongo P., Roozendaal B., Trezza V., Hauer D., Schelling G., McGaugh J.L., et al. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(12):4888-4893.
21. Campolongo P., Trezza V., Palmery M., Trabace L., Cuomo V. Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. International Review of Neurobiology 2009, 85:117-133.
22. Campolongo P., Trezza V., Ratano P., Palmery M., Cuomo V. Developmental consequences of perinatal cannabis exposure: Behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berlin) 2011, 214(1):5-15.
23. Campos A.C., Ferreira F.R., Guimaraes F.S., Lemos J.I. Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. Neuroscience 2010, 167(2):238-246.
24. Carvalho A.F., Van Bockstaele E.J. Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 38(1):59-67.
25. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annual Review of Neuroscience 2006, 29:37-76.
26. Chhatwal J.P., Davis M., Maguschak K.A., Ressler K.J. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 2005, 30(3):516-524.
27. Clarke J.R., Rossato J.I., Monteiro S., Bevilaqua L.R., Izquierdo I., Cammarota M. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory. Neurobiology of Learning and Memory 2008, 90(2):374-381.
28. Cota D., Steiner M.A., Marsicano G., Cervino C., Herman J.P., Grubler Y., et al. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 2007, 148(4):1574-1581.
29. Da S., Takahashi R.N. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002, 26(2):321-325.
30. Davis M., Rainnie D., Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends in Neurosciences 1994, 17(5):208-214.
31. de Kloet E.R., Oitzl M.S., Joels M. Stress and cognition: Are corticosteroids good or bad guys?. Trends in Neurosciences 1999, 22(10):422-426.
32. de Oliveira Alvares L., de Oliveira L.F., Camboim C., Diehl F., Genro B.P., Lanziotti V.B., et al. Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats. Neurobiology of Learning and Memory 2005, 83(2):119-124.
33. de Oliveira Alvares L., Engelke D.S., Diehl F., Scheffer-Teixeira R., Haubrich J., de Freitas Cassini L. Stress response recruits the hippocampal endocannabinoid system for the modulation of fear memory. Learning & Memory 2010, 17(4):202-209.
34. De Oliveira Alvares L., Genro B.P., Diehl F., Quillfeldt J.A. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. Neurobiology of Learning and Memory 2008, 90(1):1-9.
35. de Quervain D.J., Aerni A., Schelling G., Roozendaal B. Glucocorticoids and the regulation of memory in health and disease. Frontiers in Neuroendocrinology 2009, 30(3):358-370.
36. de Quervain D.J., Roozendaal B., McGaugh J.L. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 1998, 394(6695):787-790.
37. Del Porto J.A., Masur J. The effects of alcohol, THC and diazepam in two different social settings: A study with human volunteers. Research Communications in Psychology, Psychiatry and Behavior 1984, 9:201-212.
38. Derbenev A.V., Stuart T.C., Smith B.N. Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve. Journal of Physiology 2004, 559(Pt 3):923-938.
39. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology 1988, 34(5):605-613.
40. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258(5090):1946-1949.
41. Di S., Malcher-Lopes R., Halmos K.C., Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism. Journal of Neuroscience 2003, 23(12):4850-4857.
42. Di S., Malcher-Lopes R., Marcheselli V.L., Bazan N.G., Tasker J.G. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 2005, 146(10):4292-4301.
43. Economidou D., Mattioli L., Ubaldi M., Lourdusamy A., Soverchia L., Hardiman G., et al. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol. Toxicology and Applied Pharmacology 2007, 223(1):73-85.
44. Egashira N., Mishima K., Iwasaki K., Fujiwara M. Intracerebral microinjections of delta 9-tetrahydrocannabinol: Search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Research 2002, 952(2):239-245.
45. Fernandez-Ruiz J., Berrendero F., Hernandez M.L., Ramos J.A. The endogenous cannabinoid system and brain development. Trends in Neurosciences 2000, 23(1):14-20.
46. Ferry B., McGaugh J.L. Clenbuterol administration into the basolateral amygdala post-training enhances retention in an inhibitory avoidance task. Neurobiology of Learning and Memory 1999, 72(1):8-12.
47. Feuerecker M., Hauer D., Toth R., Demetz F., Holzl J., Thiel M., et al. Effects of exercise stress on the endocannabinoid system in humans under field conditions. European Journal of Applied Physiology 2012, 112(7):2777-2781.
48. Fisk J.E., Montgomery C. Real-world memory and executive processes in cannabis users and non-users. Journal of Psychopharmacology 2008, 22(7):727-736.
49. Fraser G.L., Wahlestedt C. Understanding gene function: Antisense knockdown versus homologous recombination knockout techniques. Welch KMA primer on carebrovascular diseases 1997, 129-133. Academic Press, San Diego, CA. L.R. Caplan, D.J. Reis, B.K. Siesjo, B. Weir (Eds.).
50. Fride E. The endocannabinoid-CB(1) receptor system in pre- and postnatal life. European Journal of Pharmacology 2004, 500(1-3):289-297.
51. Fu J., Bottegoni G., Sasso O., Bertorelli R., Rocchia W., Masetti M., et al. A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nature Neuroscience 2011, 15(1):64-69.
52. Ganon-Elazar E., Akirav I. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. Journal of Neuroscience 2009, 29(36):11078-11088.
53. Gaoni Y., Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society 1964, 86:1646-1647.
54. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379(6566):606-612.
55. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(51):18620-18625.
56. Gold P.E. Coordination of multiple memory systems. Neurobiology of Learning and Memory 2004, 82(3):230-242.
57. Gonzalez S., Fernandez-Ruiz J., Di Marzo V., Hernandez M., Arevalo C., Nicanor C., et al. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: An experimental model of cannabinoid abstinence. Drug and Alcohol Dependence 2004, 74(2):159-170.
58. Haller J., Barna I., Barsvari B., Gyimesi Pelczer K., Yasar S., Panlilio L.V., et al. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Psychopharmacology (Berlin) 2009, 204(4):607-616.
59. Haring M., Marsicano G., Lutz B., Monory K. Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 2007, 146(3):1212-1219.
60. Harkany T., Guzman M., Galve-Roperh I., Berghuis P., Devi L.A., Mackie K. The emerging functions of endocannabinoid signaling during CNS development. Trends in Pharmacological Sciences 2007, 28(2):83-92.
61. Hatfield T., Spanis C., McGaugh J.L. Response of amygdalar norepinephrine to footshock and GABAergic drugs using in vivo microdialysis and HPLC. Brain Research 1999, 835(2):340-345.
62. Hauer D., Schelling G., Gola H., Campolongo P., Morath J., Roozendaal B., et al. Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS One 2013, 8(5):e62741.
63. Hauer D., Weis F., Campolongo P., Schopp M., Beiras-Fernandez A., Strewe C., et al. Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: Relationship to early cognitive dysfunction and late depression. Reviews in the Neurosciences 2012, 23(5-6):681-690.
64. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience 1991, 11(2):563-583.
65. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., et al. Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(5):1932-1936.
66. Hermann H., Marsicano G., Lutz B. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 2002, 109(3):451-460.
67. Hill M.N., Karatsoreos I.N., Hillard C.J., McEwen B.S. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology 2010, 35(9):1333-1338.
68. Hill M.N., McEwen B.S. Endocannabinoids: The silent partner of glucocorticoids in the synapse. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(12):4579-4580.
69. Hill M.N., McEwen B.S. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010, 34(5):791-797.
70. Hill M.N., Miller G.E., Carrier E.J., Gorzalka B.B., Hillard C.J. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 2009, 34(8):1257-1262.
71. Hill M.N., Patel S., Campolongo P., Tasker J.G., Wotjak C.T., Bains J.S. Functional interactions between stress and the endocannabinoid system: From synaptic signaling to behavioral output. Journal of Neuroscience 2010, 30(45):14980-14986.
72. Hill M.N., Tasker J.G. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 2012, 204:5-16.
73. Hillard C.J., Edgemond W.S., Jarrahian A., Campbell W.B. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. Journal of Neurochemistry 1997, 69(2):631-638.
74. Hoffman A.F., Lupica C.R. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. Journal of Neuroscience 2000, 20(7):2470-2479.
75. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews 2002, 54(2):161-202.
76. Jacob W., Marsch R., Marsicano G., Lutz B., Wotjak C.T. Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo. Neurobiology of Learning and Memory 2012, 98(1):47-55.
77. Jamali-Raeufy N., Nasehi M., Zarrindast M.R. Influence of N-methyl D-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus. Behavioural Pharmacology 2011, 22(7):645-654.
78. Jelsing J., Larsen P.J., Vrang N. Identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry. Neuroscience 2008, 154(2):641-652.
79. Joels M., Baram T.Z. The neuro-symphony of stress. Nature Reviews Neuroscience 2009, 10(6):459-466.
80. Kamprath K., Romo-Parra H., Haring M., Gaburro S., Doengi M., Lutz B., et al. Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology 2010, 36(3):652-663.
81. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiological Reviews 2009, 89(1):309-380.
82. Karila L., Roux P., Rolland B., Benyamina A., Reynaud M., Aubin H.J., et al. Acute and long-term effects of cannabis use: A review. Current Pharmaceutical Design 2013.
83. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontini A., et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nature Medicine 2003, 9(1):76-81.
84. Katona I., Freund T.F. Multiple functions of endocannabinoid signaling in the brain. Annual Review of Neuroscience 2012, 35:529-558.
85. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. Journal of Neuroscience 2001, 21(23):9506-9518.
86. Katona I., Sperlagh B., Magloczky Z., Santha E., Kofalvi A., Czirjak S., et al. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 2000, 100(4):797-804.
87. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. Journal of Neuroscience 1999, 19(11):4544-4558.
88. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., et al. Molecular composition of the endocannabinoid system at glutamatergic synapses. Journal of Neuroscience 2006, 26(21):5628-5637.
89. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., et al. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. Journal of Neuroscience 2006, 26(11):2991-3001.
90. Krettek J.E., Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. Journal of Comparative Neurology 1978, 178(2):225-254.
91. LaLumiere R.T., Buen T.V., McGaugh J.L. Post-training intra-basolateral amygdala infusions of norepinephrine enhance consolidation of memory for contextual fear conditioning. Journal of Neuroscience 2003, 23(17):6754-6758.
92. Lichtman A.H. SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. European Journal of Pharmacology 2000, 404(1-2):175-179.
93. Lichtman A.H., Dimen K.R., Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology (Berlin) 1995, 119(3):282-290.
94. Lin Q.S., Yang Q., Liu D.D., Sun Z., Dang H., Liang J., et al. Hippocampal endocannabinoids play an important role in induction of long-term potentiation and regulation of contextual fear memory formation. Brain Research Bulletin 2011, 86(3-4):139-145.
95. Mackowiak M., Chocyk A., Dudys D., Wedzony K. Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning. Neuroscience 2009, 158(4):1708-1716.
96. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 1992, 48(3):655-668.
97. Maione S., Bisogno T., de Novellis V., Palazzo E., Cristino L., Valenti M., et al. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. Journal of Pharmacology and Experimental Therapeutics 2006, 316(3):969-982.
98. Manzanares J., Corchero J., Fuentes J.A. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats. Brain Research 1999, 839(1):173-179.
99. Maroun M., Akirav I. Arousal and stress effects on consolidation and reconsolidation of recognition memory. Neuropsychopharmacology 2008, 33(2):394-405.
100. Marsicano G., Lafenetre P. Roles of the endocannabinoid system in learning and memory. Current Topics in Behavioral Neurosciences 2009, 1:201-230.
101. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. European Journal of Neuroscience 1999, 11(12):4213-4225.
102. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418(6897):530-534.
103. Matsuda L.A., Bonner T.I., Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. Journal of Comparative Neurology 1993, 327(4):535-550.
104. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346(6284):561-564.
105. Mazzola C., Medalie J., Scherma M., Panlilio L.V., Solinas M., Tanda G., et al. Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learning & Memory 2009, 16(5):332-337.
106. McEwen B.S. Brain on stress: How the social environment gets under the skin. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(Suppl. 2):17180-17185.
107. McGaugh J.L. Time-dependent processes in memory storage. Science 1966, 153:1351-1358.
108. McGaugh J.L. Memory - A century of consolidation. Science 2000, 287(5451):248-251.
109. McGaugh J.L., Roozendaal B. Role of adrenal stress hormones in forming lasting memories in the brain. Current Opinion in Neurobiology 2002, 12(2):205-210.
110. McPartland J.M., Glass M., Pertwee R.G. Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: Interspecies differences. British Journal of Pharmacology 2007, 152(5):583-593.
111. Mendl M. Performing under pressure: Stress and cognitive function. Applied Animal Behaviour Science 1999, 65:221-244.
112. Metna-Laurent M., Soria-Gómez E., Verrier D., Conforzi M., Jego P., Lafenetre P., et al. Bimodal control of fear-coping strategies by CB1 cannabinoid receptors. The Journal of Neuroscience 2012, 32(21):7109-7118.
113. Micale V., Di Marzo V., Sulcova A., Wotjak C.T., Drago F. Endocannabinoid system and mood disorders: Priming a target for new therapies. Pharmacology & Therapeutics 2013, 138(1):18-37.
114. Millan M.J. The neurobiology and control of anxious states. Progress in Neurobiology 2003, 70(2):83-244.
115. 9-tetrahydrocannabinol in rats. The Japanese Journal of Pharmacology 2001, 87:297-308.
116. Monory K., Massa F., Egertova M., Eder M., Blaudzun H., Westenbroek R., et al. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 2006, 51(4):455-466.
117. Morozov Y.M., Torii M., Rakic P. Origin, early commitment, migratory routes, and destination of cannabinoid type 1 receptor-containing interneurons. Cerebral Cortex 2009, 19(Suppl. 1):i78-i89.
118. Morrish A.C., Hill M.N., Riebe C.J., Gorzalka B.B. Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: Role of gender and noradrenergic transmission. Physiology & Behavior 2009, 98(1-2):118-124.
119. Moser E., Moser M.B., Andersen P. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. Journal of Neuroscience 1993, 13(9):3916-3925.
120. Moshfegh A., Babaei P., Oryan S., Soltani B., Zarrindast M.R. Involvement of dorsal hippocampal alpha1-adrenergic receptors in the effect of WIN55,212-2 on memory retrieval in inhibitory avoidance task. Neuroscience Letters 2011, 489(2):69-73.
121. Muntoni A.L., Pillolla G., Melis M., Perra S., Gessa G.L., Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. European Journal of Neuroscience 2006, 23(9):2385-2394.
122. Myhrer T. Neurotransmitter systems involved in learning and memory in the rat: A meta-analysis based on studies of four behavioral tasks. Brain Research. Brain Research Reviews 2003, 41(2-3):268-287.
123. Nasehi M., Sahebgharani M., Haeri-Rohani A., Zarrindast M.R. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiology of Learning and Memory 2009, 92(3):391-399.
124. Neumeister A., Normandin M.D., Pietrzak R.H., Piomelli D., Zheng M.Q., Gujarro-Anton A., et al. Elevated brain cannabinoid CB receptor availability in post-traumatic stress disorder: A positron emission tomography study. Molecular Psychiatry 2013.
125. Newsom R.J., Osterlund C., Masini C.V., Day H.E., Spencer R.L., Campeau S. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats. Neuroscience 2012, 204:64-73.
126. Niyuhire F., Varvel S.A., Martin B.R., Lichtman A.H. Exposure to marijuana smoke impairs memory retrieval in mice. Journal of Pharmacology and Experimental Therapeutics 2007, 322(3):1067-1075.
127. Niyuhire F., Varvel S.A., Thorpe A.J., Stokes R.J., Wiley J.L., Lichtman A.H. The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific. Psychopharmacology (Berlin) 2007, 191(2):223-231.
128. Ohno-Shosaku T., Maejima T., Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29(3):729-738.
129. Oitzl M.S., de Kloet E.R. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behavioral Neuroscience 1992, 106(1):62-71.
130. Okuda S., Roozendaal B., McGaugh J.L. Glucocorticoid effects on object recognition memory require training-associated emotional arousal. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(3):853-858.
131. Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Perchuk A., Meozzi P.A., et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Annals of the New York Academy of Sciences 2006, 1074:514-536.
132. Oropeza V.C., Mackie K., Van Bockstaele E.J. Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Research 2007, 1127(1):36-44.
133. Oropeza V.C., Page M.E., Van Bockstaele E.J. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Research 2005, 1046(1-2):45-54.
134. O'Sullivan S.E. Cannabinoids go nuclear: Evidence for activation of peroxisome proliferator-activated receptors. British Journal of Pharmacology 2007, 152(5):576-582.
135. Packard M.G., Wingard J.C. Amygdala and "emotional" modulation of the relative use of multiple memory systems. Neurobiology of Learning and Memory 2004, 82(3):243-252.
136. Page M.E., Oropeza V.C., Sparks S.E., Qian Y., Menko A.S., Van Bockstaele E.J. Repeated cannabinoid administration increases indices of noradrenergic activity in rats. Pharmacology, Biochemistry and Behavior 2007, 86(1):162-168.
137. Pamplona F.A., Prediger R.D., Pandolfo P., Takahashi R.N. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berlin) 2006, 188(4):641-649.
138. Pamplona F.A., Takahashi R.N. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neuroscience Letters 2006, 397(1-2):88-92.
139. Pape H.C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiological Reviews 2010, 90(2):419-463.
140. Patel S., Hillard C.J. Cannabinoid-induced Fos expression within A10 dopaminergic neurons. Brain Research 2003, 963(1-2):15-25.
141. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145(12):5431-5438.
142. Pelletier J.G., Likhtik E., Filali M., Pare D. Lasting increases in basolateral amygdala activity after emotional arousal: Implications for facilitated consolidation of emotional memories. Learning & Memory 2005, 12(2):96-102.
143. Pertwee R.G. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Current Medicinal Chemistry 2010, 17(14):1360-1381.
144. Piri M., Zarrindast M.R. Modulation of WIN55,212-2 state-dependent memory by alpha2-adrenergic receptors of the dorsal hippocampus. Archives of Iranian Medicine 2011, 14(6):389-395.
145. Pistis M., Perra S., Pillolla G., Melis M., Gessa G.L., Muntoni A.L. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: Evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 2004, 46(1):115-125.
146. Porto J.A.D., Masur J. The effects of alcohol, THC and diazepam in two different social settings. A study with human volunteers. Research Communications in Psychology, Psychiatry and Behavior 1984, 9:201-212.
147. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010, 35(1):192-216.
148. Quirarte G.L., Roozendaal B., McGaugh J.L. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(25):14048-14053.
149. Ramikie T.S., Patel S. Endocannabinoid signaling in the amygdala: Anatomy, synaptic signaling, behavior, and adaptations to stress. Neuroscience 2012, 204:38-52.
150. Ramot A., Akirav I. Cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala prevent the stress-induced enhancement of a negative learning experience. Neurobiology of Learning and Memory 2012, 97(4):393-401.
151. Ranganathan M., D'Souza D.C. The acute effects of cannabinoids on memory in humans: A review. Psychopharmacology (Berlin) 2006, 188(4):425-444.
152. Reilly D., Didcott P., Swift W., Hall W. Long-term cannabis use: Characteristics of users in an Australian rural area. Addiction 1998, 93(6):837-846.
153. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 1985, 117(6):2505-2511.
154. Riedel G., Davies SN. Cannabinoid function in learning, memory and plasticity. Handbook of Experimental Pharmacology 2005, 168:445-477.
155. Robinson L., McKillop-Smith S., Ross N.L., Pertwee R.G., Hampson R.E., Platt B., et al. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology (Berlin) 2008, 198(4):551-563.
156. Roozendaal B. 1999 Curt P. Richter award. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology 2000, 25(3):213-238.
157. Roozendaal B. Stress and memory: Opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiology of Learning and Memory 2002, 78(3):578-595.
158. Roozendaal B., Castello N.A., Vedana G., Barsegyan A., McGaugh J.L. Noradrenergic activation of the basolateral amygdala modulates consolidation of object recognition memory. Neurobiology of Learning and Memory 2008, 90(3):576-579.
159. Roozendaal B., de Quervain D.J., Schelling G., McGaugh J.L. A systemically administered beta-adrenoceptor antagonist blocks corticosterone-induced impairment of contextual memory retrieval in rats. Neurobiology of Learning and Memory 2004, 81(2):150-154.
160. Roozendaal B., Hui G.K., Hui I.R., Berlau D.J., McGaugh J.L., Weinberger N.M. Basolateral amygdala noradrenergic activity mediates corticosterone-induced enhancement of auditory fear conditioning. Neurobiology of Learning and Memory 2006, 86(3):249-255.
161. Roozendaal B., Koolhaas J.M., Bohus B. Central amygdaloid involvement in neuroendocrine correlates of conditioned stress responses. Journal of Neuroendocrinology 1992, 4(4):483-489.
162. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nature Reviews Neuroscience 2009, 10(6):423-433.
163. Roozendaal B., McGaugh J.L. Amygdaloid nuclei lesions differentially affect glucocorticoid-induced memory enhancement in an inhibitory avoidance task. Neurobiology of Learning and Memory 1996, 65(1):1-8.
164. Roozendaal B., Okuda S., Van der Zee E.A., McGaugh J.L. Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(17):6741-6746.
165. Roozendaal B., Quirarte G.L., McGaugh J.L. Glucocorticoids interact with the basolateral amygdala beta-adrenoceptor-cAMP/cAMP/PKA system in influencing memory consolidation. European Journal of Neuroscience 2002, 15(3):553-560.
166. Sandi C., Pinelo-Nava M.T. Stress and memory: Behavioral effects and neurobiological mechanisms. Neural Plasticity 2007, 2007:78970.
167. Sandi C., Rose S.P. Corticosterone enhances long-term retention in one-day-old chicks trained in a weak passive avoidance learning paradigm. Brain Research 1994, 647(1):106-112.
168. Schneider M., Schomig E., Leweke F.M. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Addiction Biology 2008, 13(3-4):345-357.
169. Sciolino N.R., Zhou W., Hohmann A.G. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. Pharmacological Research 2011, 64(3):226-234.
170. Segev A., Akirav I. Differential effects of cannabinoid receptor agonist on social discrimination and contextual fear in amygdala and hippocampus. Learning & Memory 2011, 18(4):254-259.
171. Smith H.W. Effects of set on subjects interpretation of placebo marihuana effects. Social Science and Medicine 1978, 12(2A):107-109.
172. Solinas M., Goldberg S.R. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology 2005, 30(11):2035-2045.
173. Spence K.W. Behavior theory and conditioning 1956, Yale University Press, New Haven.
174. Starowicz K., Nigam S., Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacology & Therapeutics 2007, 114(1):13-33.
175. Steiner H., Bonner T.I., Zimmer A.M., Kitai S.T., Zimmer A. Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(10):5786-5790.
176. Steiner M.A., Marsicano G., Nestler E.J., Holsboer F., Lutz B., Wotjak C.T. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 2008, 33(1):54-67.
177. Steiner M.A., Wotjak C.T. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Progress in Brain Research 2008, 170:397-432.
178. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388(6644):773-778.
179. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., et al. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications 1995, 215(1):89-97.
180. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. Journal of Neuroscience 2004, 24(20):4787-4795.
181. Szuster R.R., Pontius E.B., Campos P.E. Marijuana sensitivity and panic anxiety. Journal of Clinical Psychiatry 1988, 49(11):427-429.
182. Takahashi R.N., Pamplona F.A., Fernandes M.S. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neuroscience Letters 2005, 380(3):270-275.
183. Tan H., Lauzon N.M., Bishop S.F., Chi N., Bechard M., Laviolette S.R. Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. Journal of Neuroscience 2011, 31(14):5300-5312.
184. Trezza V., Campolongo P., Cassano T., Macheda T., Dipasquale P., Carratu M.R., et al. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: A longitudinal behavioral study in Wistar rats. Psychopharmacology (Berlin) 2008, 198(4):529-537.
185. Trezza V., Campolongo P., Manduca A., Morena M., Palmery M., Vanderschuren L.J., et al. Altering endocannabinoid neurotransmission at critical developmental ages: Impact on rodent emotionality and cognitive performance. Frontiers in Behavioral Neuroscience 2012, 6:2.
186. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83(2):393-411.
187. Turu G., Hunyady L. Signal transduction of the CB1 cannabinoid receptor. Journal of Molecular Endocrinology 2010, 44(2):75-85.
188. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310(5746):329-332.
189. van Stegeren A.H., Roozendaal B., Kindt M., Wolf O.T., Joels M. Interacting noradrenergic and corticosteroid systems shift human brain activation patterns during encoding. Neurobiology of Learning and Memory 2010, 93(1):56-65.
190. Varvel S.A., Anum E., Niyuhire F., Wise L.E., Lichtman A.H. Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline. Psychopharmacology (Berlin) 2005, 178(2-3):317-327.
191. Varvel S.A., Wise L.E., Niyuhire F., Cravatt B.F., Lichtman A.H. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. Neuropsychopharmacology 2007, 32(5):1032-1041.
192. Velez C.N., Ungemack J.A. Drug use among Puerto Rican youth: An exploration of generational status differences. Social Science and Medicine 1989, 29(6):779-789.
193. Verdejo-Garcia A., Bechara A., Recknor E.C., Perez-Garcia M. Executive dysfunction in substance dependent individuals during drug use and abstinence: An examination of the behavioral, cognitive and emotional correlates of addiction. Journal of the International Neuropsychological Society 2006, 12(3):405-415.
194. Wegener N., Kuhnert S., Thuns A., Roese R., Koch M. Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats. Psychopharmacology (Berlin) 2008, 198(3):375-385.
195. Weidenfeld J., Feldman S., Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology 1994, 59(2):110-112.
196. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410(6828):588-592.
197. Wise L.E., Iredale P.A., Lichtman A.H. The cannabinoid CB(1) receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task. European Journal of Pharmacology 2008, 590(1-3):246-249.
198. Wise L.E., Long K.A., Abdullah R.A., Long J.Z., Cravatt B.F., Lichtman A.H. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice. ACS Chemical Neuroscience 2012, 3(5):369-378.
199. Wise L.E., Thorpe A.J., Lichtman A.H. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. Neuropsychopharmacology 2009, 34(9):2072-2080.
200. Wolff M.C., Leander J.D. SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. European Journal of Pharmacology 2003, 477(3):213-217.
201. Wotjak C.T. Role of endogenous cannabinoids in cognition and emotionality. Mini Reviews in Medicinal Chemistry 2005, 5(7):659-670.
202. Yerkes R.M., Dodson J.D. The relation of strength of stimulus to rapidity of habit-formation. Journal of Comparative Neurology and Psychology 1908, 18:459-482.
203. Yim T.T., Hong N.S., Ejaredar M., McKenna J.E., McDonald R.J. Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus. Neuroscience 2008, 151(4):929-936.
204. Zanettini C., Panlilio L.V., Alicki M., Goldberg S.R., Haller J., Yasar S. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Frontiers in Behavioral Neuroscience 2011, 5:57.
205. Zarrindast M.R., Ghiasvand M., Rezayof A., Ahmadi S. The amnesic effect of intra-central amygdala administration of a cannabinoid CB1 receptor agonist, WIN55,212-2, is mediated by a beta-1 noradrenergic system in rat. Neuroscience 2012, 212:77-85.
206. Zarrindast M.R., Navaeian M., Nasehi M. Influence of three-day morphine-treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus in rats. Neuroscience Research 2011, 69(1):51-59.
207. Ziegler C.G., Mohn C., Lamounier-Zepter V., Rettori V., Bornstein S.R., Krug A.W., et al. Expression and function of endocannabinoid receptors in the human adrenal cortex. Hormone and Metabolic Research 2010, 42(2):88-92.
208. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(10):5780-5785.
209. Zinberg N.E. Drugs, set and setting: The basis for controlled intoxicant use 1984, Yale University Press, New Haven, CT.